Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study.

Ariyon Schreiber Justin S Bauzon Kavita BatraSalman MohammedKevin LeeNazanin Houshmand Uyen Pham Celica Cosme Kim InciongOmar Al-TaweelKeaton NasserJibran RanaChris SossouAriel GoDalia HawwassJimmy DiepChowdhury H Ahsan

Published in: Clinical drug investigation (2022)

Bradycardia that occurs during or shortly after remdesivir treatment in COVID-19 patients may be associated with an increased rate of in-hospital mortality. However, COVID-19 and its cardiac complications cannot be excluded as potential contributors of bradycardia in the present study. Future studies are needed to further delineate the cardiac characteristics of COVID-19 and remdesivir.

Keyphrases

sars cov
coronavirus disease
left ventricular
respiratory syndrome coronavirus
heart failure
risk assessment
climate change
human health
combination therapy